ListingsPrice list
Arch Pharmalabs Limited

Arch Pharmalabs LimitedUnlisted Share Price ₹85

Pharmaceuticalsas of 27 Aug 2026 ISTISIN INE182F01017

Ask price

₹85

▲ +0.0%

Bid

₹80

Arch Pharmalabs Limited unlisted share price is ₹85 as of 27 Aug 2026 IST. Lot size is 250 shares. Minimum investment is ₹21,250. Off-market transfer to your NSDL & CDSL demat, typically T+0.

Lot size

250 shares

Min. investment

₹21,250

Market cap

₹1,330.08 Cr

P/E

10.9

ROE

14.57%

P/B

1.57

Price history

How to buy this name

  1. 1

    Request a quote

    WhatsApp or the form on this page — no account required. Today’s Arch Pharmalabs Limited price is ₹85.

  2. 2

    Confirm the lot

    Minimum lot is 250 shares. Minimum investment ₹21,250. ShareSaathi confirms availability before you pay.

  3. 3

    Pay and complete KYC

    Pay ShareSaathi. First-time buyers complete KYC before the off-market transfer.

  4. 4

    Demat credit

    Shares credit to your NSDL & CDSL demat, typically T+0. ISIN INE182F01017. RTA Link Intime.

About Arch Pharmalabs Limited unlisted shares

Arch Pharmalabs Limited unlisted shares trade off-market in India in the Pharmaceuticals sector. The Arch Pharmalabs Limited unlisted share price is ₹85 as of 27 Aug 2026 IST. Market cap ₹1,330.08 Cr on the latest unlisted print. Lot size 250 shares. Request a WhatsApp quote to settle a lot into your demat — this is not an exchange order.

ARCH PHARMALABS LIMITED , a Pharmaceutical Company aligned across two business verticals viz. Products and Services. Company’s Products business comprises manufacturing and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both…

Investment risks

  • Unlisted shares are illiquid and may take time to sell.
  • There is no SEBI-mandated investor protection fund for unlisted markets.
  • Valuations can be subjective and differ from listed equities.

Frequently asked questions

What is the current share price of Arch Pharmalabs Limited?

The current unlisted share price of Arch Pharmalabs Limited is ₹85.

What is the market cap of Arch Pharmalabs Limited?

The Arch Pharmalabs Limited market cap is ₹1,330.08 Cr, based on the latest unlisted share price and shares outstanding.

What is the valuation of Arch Pharmalabs Limited?

The current valuation of Arch Pharmalabs Limited is estimated at ₹1,330.08 Cr.

How can I buy Arch Pharmalabs Limited unlisted shares?

You can buy Arch Pharmalabs Limited unlisted shares in India by requesting a quote on ShareSaathi (WhatsApp or the form on this page — no account required). Settlement is an off-market demat transfer (ISIN INE182F01017), typically T+0 (same day, under 24 hours). KYC is required before the shares credit.

What is the minimum investment required for Arch Pharmalabs Limited pre-IPO shares?

The minimum investment for Arch Pharmalabs Limited is ₹21,250, based on a lot size of 250 shares at ₹85 each.

Are Arch Pharmalabs Limited unlisted shares a good investment?

Arch Pharmalabs Limited unlisted shares are illiquid bilateral trades, not exchange orders. A future listing is not guaranteed and can re-price the name down as well as up. Review the live price, lot size, and risks on ShareSaathi before you act.

Related unlisted shares

Same sector: Pharmaceuticals

Anglo-French Drugs & Industries Ltd
Anglo-French Drugs & Industries Ltd
Pharmaceuticals · ₹0
Deys Medical Stores (Mfg) Limited
Deys Medical Stores (Mfg) Limited
Pharmaceuticals · ₹539
East India Pharmaceutical Works Limited
East India Pharmaceutical Works Limited
Pharmaceuticals · ₹79
Lords Mark Industries Limited
Lords Mark Industries Limited
Pharmaceuticals · ₹74

Trade Arch Pharmalabs

Fixed offer price

₹85

Lot

250 sh

Min. invest

₹21,250

Call

Minimum lot size applies. Settlement T+0 — typically the same day.

How this trade works

  • Off-market lot into your demat, typically T+0 (same day, under 24 hours).
  • Quote and WhatsApp with no account required.

Disclaimer: Unlisted shares are not traded on any stock exchange and carry higher risk. Prices are indicative and may vary. Please conduct your own research or consult a financial advisor before investing.

Call